| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
|
Hickish, Tamas
|
|
|
192 |
3 |
p. 593-602
|
artikel
|
| 2 |
A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing
|
Fridman, Ilona
|
|
|
192 |
3 |
p. 517-527
|
artikel
|
| 3 |
Axillary surgery and complication rates after mastectomy and reconstruction for breast cancer: an analysis of the NSQIP database
|
Bogach, Jessica
|
|
|
192 |
3 |
p. 501-508
|
artikel
|
| 4 |
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
|
Okines, Alicia
|
|
|
192 |
3 |
p. 563-571
|
artikel
|
| 5 |
Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer
|
Dirix, Luc Y.
|
|
|
192 |
3 |
p. 583-591
|
artikel
|
| 6 |
Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
|
Jacobs, C. F.
|
|
|
192 |
3 |
p. 485-489
|
artikel
|
| 7 |
Diagnostic performance improvement with combined use of proteomics biomarker assay and breast ultrasound
|
Ha, Su Min
|
|
|
192 |
3 |
p. 541-552
|
artikel
|
| 8 |
Differences in somatic TP53 mutation type in breast tumors by race and receptor status
|
Pollock, Nijole C.
|
|
|
192 |
3 |
p. 639-648
|
artikel
|
| 9 |
Endocrine adherence in male versus female breast cancer: a seer-medicare review
|
Ali, Azka
|
|
|
192 |
3 |
p. 491-499
|
artikel
|
| 10 |
Examining the prevalence of homologous recombination repair defects in ER+ breast cancers
|
Moore, Grace M.
|
|
|
192 |
3 |
p. 649-653
|
artikel
|
| 11 |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin, Po-Han
|
|
|
192 |
3 |
p. 629-637
|
artikel
|
| 12 |
Nanoparticle-assisted axillary staging: an alternative approach after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers
|
Yang, Jiqiao
|
|
|
192 |
3 |
p. 573-582
|
artikel
|
| 13 |
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?
|
Morganti, Stefania
|
|
|
192 |
3 |
p. 465-484
|
artikel
|
| 14 |
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
|
Palassini, E.
|
|
|
192 |
3 |
p. 603-610
|
artikel
|
| 15 |
The effect of emotional disorders on adherence to mammography screening guidelines
|
Yazgan, Idil
|
|
|
192 |
3 |
p. 623-627
|
artikel
|
| 16 |
Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017
|
Vo, Jacqueline B.
|
|
|
192 |
3 |
p. 611-622
|
artikel
|
| 17 |
Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
|
Kariri, Yousif
|
|
|
192 |
3 |
p. 529-539
|
artikel
|
| 18 |
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer
|
Nguyen, Thi Truc Anh
|
|
|
192 |
3 |
p. 509-516
|
artikel
|
| 19 |
Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05)
|
Byun, Hwa Kyung
|
|
|
192 |
3 |
p. 553-561
|
artikel
|
Tijdschrift beschrijving